Black Diamond Therapeutics BDTX 深 沪
等待开盘 03-26 09:30:00 美东时间
2.19
+0.050
+2.34%
华盛通- 最 高2.27
- 今 开2.19
- 成交量 39.57万股
- 最 低 2.19
- 昨 收 2.14
- 总市值 1.25亿
- 52周最高 4.94
- 市盈率 静 5.64
- 换手率 0.69%
- 52周最低 1.195
- 委 比 54.00%
- 总股本 5697.49万
- 历史最高 46.25
- 量 比 0.83
- 振 幅 3.74%
- 历史最低 1.18
- 每 手 1
- 风险率 0.76%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 摩根大通上调哔哩哔哩至"超配"，目标价从27美元升至35美元；Rhythm遭花旗、大摩等多家机构下调目标价
今日重点评级关注：韦德布什：维持Black Diamond Therapeutic"跑赢大市"评级，目标价从13美元升至14美元；花旗：维持Olema Pharmaceuticals"买入"评级，目标价从60美元升至62美元
03-18 10:48
Black Diamond Therapeutic Q4 EPS $(0.27) Misses $(0.19) Estimate
Black Diamond Therapeutic (NASDAQ:BDTX) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.19) by 41.36 percent. This is a 3.57 percent increase over losses of $(0.28) per
03-17 04:04
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Black Diamond Therapeutics reported $128.7 million in cash as of December 2025, sufficient for operations into 2H 2028. The company plans to present Phase 2 trial updates for silevertinib in non-classical EGFRm NSCLC in Q2 2026 and initiate a randomized Phase 2 trial for newly diagnosed EGFR-altered GBM in Q2 2026. R&D expenses decreased to $33.6 million in 2025, with G&A expenses down to $16.6 million. The company reported a net income of $22.4 ...
03-16 20:01
Black Diamond (BDI) Signals Growth Despite Near-Term Lumps
Black Diamond (BDI) (($TSE:BDI)) has held its Q4 earnings call. Read on for the...
03-08 08:20
Clarus Analysts Slash Their Forecasts After Q4 Earnings
Clarus Corp (NASDAQ:CLAR) reported mixed Q4 results, meeting earnings expectations but missing sales estimates. Shares fell 4.2% to $2.97. Analysts have lowered price targets for the stock.
03-07 02:20
Clarus Announces $0.025 Per Share Quarterly Dividend
Clarus Corporation has announced a quarterly cash dividend of $0.025 per share, payable on March 25, 2026, to stockholders of record as of March 16, 2026. The company, based in Salt Lake City, Utah, specializes in outdoor equipment and lifestyle products, operating under well-known brands such as Black Diamond, Rhino-Rack, MAXTRAX, TRED Outdoors, and RockyMounts. Clarus emphasizes safety, simplicity, effectiveness, and aesthetics in its products ...
03-04 21:15
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
<p>Black Diamond Therapeutics, Inc. (NASDAQ: BDTX), a clinical-stage oncology company, announced its participation in upcoming investor conferences. CEO Mark Velleca, M.D., Ph.D., and CSO Elizabeth Buck, Ph.D., will present at the 46th Annual TD Cowen Healthcare Conference on March 4, 2026, and the 25th Annual Needham Virtual Healthcare Conference on April 15, 2026. Webcasts will be available on the company’s investor relations website, www.black...
03-02 21:01
Black Diamond Group Limited declares CAD 0.045 dividend
Black Diamond Group Limited (BDI:CA) declares CAD 0.045/share quarterly dividend, in line with previous. Payable April 15; for shareholders of record March 31; ex-div March 31. See BDI:CA Dividend Sco...
02-27 14:06
Black Diamond Gr Q4 EPS $0.11 Misses $0.16 Estimate, Sales $144.000M Beat $114.373M Estimate
Black Diamond Gr (TSX:BDI) reported quarterly earnings of $0.11 per share which missed the analyst consensus estimate of $0.16 by 31.25 percent. This is a 26.67 percent decrease over earnings of $0.15 per share from the
02-27 06:07
